These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 17620332)

  • 1. Role of c-Abl in directing metabolic versus mitogenic effects in insulin receptor signaling.
    Frasca F; Pandini G; Malaguarnera R; Mandarino A; Messina RL; Sciacca L; Belfiore A; Vigneri R
    J Biol Chem; 2007 Sep; 282(36):26077-88. PubMed ID: 17620332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Abl and insulin receptor signalling.
    Genua M; Pandini G; Cassarino MF; Messina RL; Frasca F
    Vitam Horm; 2009; 80():77-105. PubMed ID: 19251035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib induces apoptosis by inhibiting PDGF- but not insulin-induced PI 3-kinase/Akt survival signaling in RGC-5 retinal ganglion cells.
    Biswas SK; Zhao Y; Sandirasegarane L
    Mol Vis; 2009 Aug; 15():1599-610. PubMed ID: 19693287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Janus kinase 2: a critical target in chronic myelogenous leukemia.
    Samanta AK; Lin H; Sun T; Kantarjian H; Arlinghaus RB
    Cancer Res; 2006 Jul; 66(13):6468-72. PubMed ID: 16818614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
    Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
    Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal adhesion kinase mediates cell survival via NF-kappaB and ERK signaling pathways.
    Huang D; Khoe M; Befekadu M; Chung S; Takata Y; Ilic D; Bryer-Ash M
    Am J Physiol Cell Physiol; 2007 Apr; 292(4):C1339-52. PubMed ID: 17135301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct angiogenic mediators are required for basic fibroblast growth factor- and vascular endothelial growth factor-induced angiogenesis: the role of cytoplasmic tyrosine kinase c-Abl in tumor angiogenesis.
    Yan W; Bentley B; Shao R
    Mol Biol Cell; 2008 May; 19(5):2278-88. PubMed ID: 18353972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile response to Hepatocyte Growth Factor.
    Frasca F; Vigneri P; Vella V; Vigneri R; Wang JY
    Oncogene; 2001 Jun; 20(29):3845-56. PubMed ID: 11439348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.
    Frolov A; Evans IM; Li N; Sidlauskas K; Paliashvili K; Lockwood N; Barrett A; Brandner S; Zachary IC; Frankel P
    Sci Rep; 2016 Jun; 6():27378. PubMed ID: 27293031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling.
    Warshamana-Greene GS; Litz J; Buchdunger E; Hofmann F; García-Echeverría C; Krystal GW
    Mol Cancer Ther; 2004 May; 3(5):527-35. PubMed ID: 15141010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminopeptidase inhibitors inhibit proliferation and induce apoptosis of K562 and STI571-resistant K562 cell lines through the MAPK and GSK-3beta pathways.
    Sawafuji K; Miyakawa Y; Weisberg E; Griffin JD; Ikeda Y; Kizaki M
    Leuk Lymphoma; 2003 Nov; 44(11):1987-96. PubMed ID: 14738154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic interactions between imatinib mesylate and the novel phosphoinositide-dependent kinase-1 inhibitor OSU-03012 in overcoming imatinib mesylate resistance.
    Tseng PH; Lin HP; Zhu J; Chen KF; Hade EM; Young DC; Byrd JC; Grever M; Johnson K; Druker BJ; Chen CS
    Blood; 2005 May; 105(10):4021-7. PubMed ID: 15665113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Akt and mitogen-activated protein kinase enhance C-type lectin-like receptor 2-mediated platelet activation by inhibition of glycogen synthase kinase 3α/β.
    Moroi AJ; Watson SP
    J Thromb Haemost; 2015 Jun; 13(6):1139-50. PubMed ID: 25858425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of GSK3β promotes imatinib-mediated apoptosis in quiescent CD34+ chronic myeloid leukemia progenitors, preserving normal stem cells.
    Reddiconto G; Toto C; Palamà I; De Leo S; de Luca E; De Matteis S; Dini L; Passerini CG; Di Renzo N; Maffia M; Coluccia AM
    Blood; 2012 Mar; 119(10):2335-45. PubMed ID: 22262776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the p38 mitogen-activated protein kinase pathway in the generation of the effects of imatinib mesylate (STI571) in BCR-ABL-expressing cells.
    Parmar S; Katsoulidis E; Verma A; Li Y; Sassano A; Lal L; Majchrzak B; Ravandi F; Tallman MS; Fish EN; Platanias LC
    J Biol Chem; 2004 Jun; 279(24):25345-52. PubMed ID: 15056660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphorylation of RACK1 on tyrosine 52 by c-Abl is required for insulin-like growth factor I-mediated regulation of focal adhesion kinase.
    Kiely PA; Baillie GS; Barrett R; Buckley DA; Adams DR; Houslay MD; O'Connor R
    J Biol Chem; 2009 Jul; 284(30):20263-74. PubMed ID: 19423701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-ABL modulates MAP kinases activation downstream of VEGFR-2 signaling by direct phosphorylation of the adaptor proteins GRB2 and NCK1.
    Anselmi F; Orlandini M; Rocchigiani M; De Clemente C; Salameh A; Lentucci C; Oliviero S; Galvagni F
    Angiogenesis; 2012 Jun; 15(2):187-97. PubMed ID: 22327338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.